TRASI, S. S.; SASHIDHARAN, N. Itolizumab as the First Line of Treatment in Moderate to Severe Chronic Plaque Psoriasis- A Case Report. Asian Journal of Pharmaceutical and Clinical Research, [S. l.], v. 9, n. 2, p. 12, 2016. Disponível em: https://mail.innovareacademics.in/journals/index.php/ajpcr/article/view/10418. Acesso em: 6 oct. 2024.